1. Home
  2. VYNE vs IFBD Comparison

VYNE vs IFBD Comparison

Compare VYNE & IFBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYNE
  • IFBD
  • Stock Information
  • Founded
  • VYNE 2003
  • IFBD 2001
  • Country
  • VYNE United States
  • IFBD China
  • Employees
  • VYNE N/A
  • IFBD N/A
  • Industry
  • VYNE Biotechnology: Pharmaceutical Preparations
  • IFBD Computer Software: Prepackaged Software
  • Sector
  • VYNE Health Care
  • IFBD Technology
  • Exchange
  • VYNE Nasdaq
  • IFBD Nasdaq
  • Market Cap
  • VYNE 7.9M
  • IFBD 8.4M
  • IPO Year
  • VYNE 2018
  • IFBD 2021
  • Fundamental
  • Price
  • VYNE $0.30
  • IFBD $1.09
  • Analyst Decision
  • VYNE Buy
  • IFBD
  • Analyst Count
  • VYNE 2
  • IFBD 0
  • Target Price
  • VYNE $8.00
  • IFBD N/A
  • AVG Volume (30 Days)
  • VYNE 1.7M
  • IFBD 648.2K
  • Earning Date
  • VYNE 11-06-2025
  • IFBD 01-01-0001
  • Dividend Yield
  • VYNE N/A
  • IFBD N/A
  • EPS Growth
  • VYNE N/A
  • IFBD N/A
  • EPS
  • VYNE N/A
  • IFBD N/A
  • Revenue
  • VYNE $476,000.00
  • IFBD $4,861,442.00
  • Revenue This Year
  • VYNE N/A
  • IFBD N/A
  • Revenue Next Year
  • VYNE N/A
  • IFBD N/A
  • P/E Ratio
  • VYNE N/A
  • IFBD N/A
  • Revenue Growth
  • VYNE N/A
  • IFBD 1520.48
  • 52 Week Low
  • VYNE $0.28
  • IFBD $0.89
  • 52 Week High
  • VYNE $4.30
  • IFBD $3.32
  • Technical
  • Relative Strength Index (RSI)
  • VYNE 31.65
  • IFBD 53.59
  • Support Level
  • VYNE $0.30
  • IFBD $1.07
  • Resistance Level
  • VYNE $0.33
  • IFBD $1.18
  • Average True Range (ATR)
  • VYNE 0.02
  • IFBD 0.09
  • MACD
  • VYNE 0.02
  • IFBD 0.01
  • Stochastic Oscillator
  • VYNE 39.80
  • IFBD 49.73

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

About IFBD Infobird Co. Ltd

Infobird Co Ltd is engaged in developing and providing customer engagement cloud-based services. It software-as-a-service provider of AI-powered, or artificial intelligence-enabled, customer engagement solutions in China. It provides holistic software solutions to help corporate clients proactively deliver and manage end-to-end customer engagement activities at all stages of the sales process, including pre-sales and sales activities, and post-sales customer support. It also offers AI-powered cloud-based sales force management software, including intelligent quality inspection and intelligent training software to help clients monitor, benchmark, and improve the performance of agents.

Share on Social Networks: